DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 129 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is 2.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,173,471 | +8.4% | 177,137 | +5.5% | 0.00% | 0.0% |
| Q2 2023 | $2,004,941 | -10.9% | 167,918 | -0.2% | 0.00% | 0.0% |
| Q1 2023 | $2,250,639 | +522.2% | 168,335 | +901.4% | 0.00% | – |
| Q4 2022 | $361,751 | +55.9% | 16,810 | +44.9% | 0.00% | – |
| Q3 2022 | $232,000 | +17.2% | 11,598 | +5.0% | 0.00% | – |
| Q2 2022 | $198,000 | +50.0% | 11,044 | -16.7% | 0.00% | – |
| Q1 2022 | $132,000 | +16.8% | 13,263 | +97.9% | 0.00% | – |
| Q4 2021 | $113,000 | -24.7% | 6,702 | +5.7% | 0.00% | – |
| Q3 2021 | $150,000 | – | 6,339 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 2,548,403 | $54,841,633 | 43.06% |
| PATHWAY CAPITAL MANAGEMENT, LP | 995,686 | $21,427,163 | 38.24% |
| Atlas Venture Life Science Advisors, LLC | 7,568,317 | $162,870,182 | 19.62% |
| RA Capital Management | 7,040,622 | $151,514,185 | 3.07% |
| COMMODORE CAPITAL LP | 739,661 | $15,918 | 2.40% |
| GREAT POINT PARTNERS LLC | 544,451 | $11,716,586 | 2.30% |
| Nicholas Investment Partners, LP | 786,554 | $16,926,642 | 1.48% |
| Boxer Capital, LLC | 1,189,943 | $25,607,573 | 1.35% |
| Parkman Healthcare Partners LLC | 224,483 | $4,830,874 | 1.29% |
| Cheyne Capital Management (UK) LLP | 27,223 | $585,839 | 1.02% |